DK1259250T3 - Endoparasiticide midler - Google Patents

Endoparasiticide midler

Info

Publication number
DK1259250T3
DK1259250T3 DK01911623T DK01911623T DK1259250T3 DK 1259250 T3 DK1259250 T3 DK 1259250T3 DK 01911623 T DK01911623 T DK 01911623T DK 01911623 T DK01911623 T DK 01911623T DK 1259250 T3 DK1259250 T3 DK 1259250T3
Authority
DK
Denmark
Prior art keywords
endoparasitic agents
endoparasitic
agents
Prior art date
Application number
DK01911623T
Other languages
Danish (da)
English (en)
Inventor
Jochen Kalbe
Achim Harder
Norbert Mencke
Michael Traeubel
Samson-Himmelstjerna Georg Von
Michael Stegemann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1259250T3 publication Critical patent/DK1259250T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01911623T 2000-02-22 2001-02-09 Endoparasiticide midler DK1259250T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (fr) 2000-02-22 2001-02-09 Agents endoparasiticides

Publications (1)

Publication Number Publication Date
DK1259250T3 true DK1259250T3 (da) 2007-02-26

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01911623T DK1259250T3 (da) 2000-02-22 2001-02-09 Endoparasiticide midler

Country Status (25)

Country Link
US (1) US20030125244A1 (fr)
EP (1) EP1259250B1 (fr)
JP (2) JP5596249B2 (fr)
KR (1) KR100755414B1 (fr)
CN (1) CN1309415C (fr)
AR (2) AR028218A1 (fr)
AT (1) ATE343394T1 (fr)
AU (2) AU4060501A (fr)
BR (1) BR0108562B1 (fr)
CA (1) CA2400610C (fr)
CZ (1) CZ300242B6 (fr)
DE (2) DE10008128A1 (fr)
DK (1) DK1259250T3 (fr)
ES (1) ES2274871T3 (fr)
HK (1) HK1054326B (fr)
HU (1) HUP0204554A3 (fr)
IL (2) IL150988A0 (fr)
MX (1) MXPA02008210A (fr)
NO (1) NO328949B1 (fr)
NZ (1) NZ520856A (fr)
PL (1) PL203999B1 (fr)
PT (1) PT1259250E (fr)
RU (1) RU2292905C2 (fr)
WO (1) WO2001062268A1 (fr)
ZA (1) ZA200205982B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
MXPA05005032A (es) * 2002-11-12 2008-02-05 Kitasato Inst Sustancia fki-1033 novedosa y proceso para producir la misma.
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
RS52236B (en) 2008-08-28 2012-10-31 Pfizer Inc. DIOKASA-BICYCLE DERIVATIVES (3.2.1) OCTOBER-2,3,4-TRIOLA
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
RS62130B1 (sr) * 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
RU2715556C2 (ru) 2015-12-28 2020-03-02 Мериал, Инк. Противогельминтные депсипептидные соединения
WO2018093920A1 (fr) 2016-11-16 2018-05-24 Merial, Inc. Composés depsipeptidiques anthelminthiques
US20220331314A1 (en) 2019-08-14 2022-10-20 Vetoquinol Sa Compositions comprising tigolaner for controlling parasites

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
WO1993019053A1 (fr) * 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Derive de depsipeptide, production et utilisation
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (fr) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha Preparation sous forme de solution a base d'une forte concentration d'aureobasidine
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
JP4098474B2 (ja) * 1998-03-19 2008-06-11 メルク エンド カムパニー インコーポレーテッド 外部寄生虫侵入防除用硫黄ペンタフルオロフェニルピラゾール
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
HK1054326B (zh) 2007-11-09
US20030125244A1 (en) 2003-07-03
KR20020072577A (ko) 2002-09-16
PL357551A1 (en) 2004-07-26
PL203999B1 (pl) 2009-11-30
BR0108562B1 (pt) 2013-03-05
IL150988A0 (en) 2003-02-12
AR085989A2 (es) 2013-11-13
DE10008128A1 (de) 2001-08-23
ZA200205982B (en) 2003-07-28
HUP0204554A3 (en) 2005-05-30
CN1404397A (zh) 2003-03-19
AR028218A1 (es) 2003-04-30
AU2001240605B2 (en) 2005-04-21
CA2400610C (fr) 2013-01-22
IL150988A (en) 2011-06-30
HK1054326A1 (en) 2003-11-28
CA2400610A1 (fr) 2001-08-30
WO2001062268A1 (fr) 2001-08-30
DE50111315D1 (de) 2006-12-07
AU4060501A (en) 2001-09-03
BR0108562A (pt) 2002-11-12
RU2002125493A (ru) 2004-03-20
CZ20022867A3 (cs) 2003-01-15
ATE343394T1 (de) 2006-11-15
HUP0204554A2 (en) 2003-05-28
JP5596249B2 (ja) 2014-09-24
EP1259250A1 (fr) 2002-11-27
PT1259250E (pt) 2007-01-31
NO20023976L (no) 2002-10-21
ES2274871T3 (es) 2007-06-01
NO20023976D0 (no) 2002-08-21
EP1259250B1 (fr) 2006-10-25
MXPA02008210A (es) 2003-01-28
JP2003523397A (ja) 2003-08-05
NO328949B1 (no) 2010-06-28
JP2012107024A (ja) 2012-06-07
CZ300242B6 (cs) 2009-03-25
KR100755414B1 (ko) 2007-09-04
RU2292905C2 (ru) 2007-02-10
NZ520856A (en) 2005-04-29
CN1309415C (zh) 2007-04-11

Similar Documents

Publication Publication Date Title
DK1309591T3 (da) Substituerede pyrazoler
CY1104912T1 (el) Υποκατεστημενα πυραζολια
DZ3409A1 (fr) Association therapeuthique
NO20030472L (no) Imidazolderivater
NO20023953D0 (no) Pyridinylimidazoler
NO20025821D0 (no) 2-aminokarbonyl-9H-purinderivater
DE60133295D1 (de) Sulphoniumsalz-verbindung
NO20031869L (no) Antiinflammatoriske midler
DE60107598D1 (de) Smart-skin strukturen
EE200200420A (et) Linesoliid - kristallivorm II
DE60121447D1 (de) Tetrazolderivate
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
NO20023246L (no) Hårstylingsfremgangsmåte
PT1303188E (pt) Agentes herbicidas
DE60009651D1 (de) Hochfrequenzscalter
DK1259250T3 (da) Endoparasiticide midler
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
DE60129224D1 (de) Tetrazolderivate
AR027982A1 (es) Aril- y heteroarilsulfonatos
DK1180326T3 (da) o-Phenylphenolat-koncentrater
AT500246B8 (de) Chokerring
FR2817889B1 (fr) Coffrage
ATA11602000A (de) Sonnenstandsnachführungssystem
NO20003797D0 (no) Brannsikring